Supplier
Blood & Cancer Center INC
Blood & Cancer Center INC was paid $1.17M by Medicaid between Jan 2018 and Nov 2024, across 29 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 28% of everything it billed.
33Billing provider infoBLOOD & CANCER CENTER INC
CANFIELD, OH 44406
CANFIELD, OH 44406
33aNPI1689860207assigned 09/18/2007
33bProvider typeNon-Pharmacy Dispensing Site
28Total paid$1.17M
24GClaims90,156
24DCodes billed29
24AFirst – last monthJan 2018 – Nov 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,972 | $118K | |
| 2019 | 12,437 | $176K | |
| 2020 | 13,449 | $205K | |
| 2021 | 15,330 | $228K | |
| 2022 | 14,700 | $177K | |
| 2023 | 12,877 | $126K | |
| 2024incomplete | 11,391 | $143K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 28% | 14,421 | 11,772 | $327K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 18% | 3,945 | 1,970 | $217K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.6% | 3,504 | 2,812 | $113K |
| J0897 | Injection, denosumab, 1 mg | 7.5% | 81 | 73 | $88K |
| 80053 | Comprehensive metabolic panel | 6.3% | 13,933 | 10,559 | $74K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.5% | 16,391 | 11,735 | $64K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 5.5% | 3,664 | 2,251 | $64K |
| 96375 | Therapeutic injection; each additional sequential IV push | 5.4% | 3,465 | 1,818 | $64K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3.2% | 1,121 | 645 | $38K |
| 36415 | Collection of venous blood by venipuncture | 2.2% | 16,672 | 11,786 | $26K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.4% | 2,314 | 1,585 | $16K |
| 82728 | 1.2% | 2,179 | 2,010 | $14K |
17 more codes
| 99204 | Doctor's office visit, new patient (more involved) | 1.0% | 189 | $12K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 242 | $9K |
| 83500 | <1% | 735 | $8K | |
| 82378 | <1% | 926 | $7K | |
| 84466 | <1% | 1,267 | $7K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 145 | $7K |
| 83540 | <1% | 2,095 | $6K | |
| 99223 | Prolong inpt eval add15 m | <1% | 116 | $5K |
| 96417 | <1% | 93 | $4K | |
| 96367 | <1% | 110 | $1K | |
| 86300 | <1% | 129 | $1K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 16 | $361.92 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 479 | $303.34 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 586 | $293.37 |
| 96401 | <1% | 15 | $279.03 | |
| 83550 | <1% | 1,311 | $212.34 | |
| 82607 | <1% | 12 | $80.88 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialORTIZ ALVARADO, MARIA (BILLING/CREDENTIALING)